Douglas Vincent Faller
CIK: 0002056033
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Imunon, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 23, 2026IMNN
Imunon, Inc.
Award(A)Direct1.1K shares at avg. $1.24$1K - Oct 23, 2026IMNN
Imunon, Inc.
Award(A)Direct26.7K shares at avg. $1.24$33K - Oct 9, 2026IMNN
Imunon, Inc.
Award(A)Direct1.2K shares at avg. $1.08$1K - Sep 25, 2026IMNN
Imunon, Inc.
Award(A)Direct4.4K shares at avg. $1.41$6K - Sep 11, 2026IMNN
Imunon, Inc.
Award(A)Direct4.2K shares at avg. $1.47$6K - Aug 28, 2026IMNN
Imunon, Inc.
Award(A)Direct3.6K shares at avg. $1.60$6K - Aug 14, 2026IMNN
Imunon, Inc.
Award(A)Direct3.5K shares at avg. $1.65$6K - Jul 31, 2026IMNN
Imunon, Inc.
Award(A)Direct3.6K shares at avg. $1.59$6K - Jul 17, 2026IMNN
Imunon, Inc.
Award(A)Direct3.1K shares at avg. $1.83$6K - Jul 2, 2026IMNN
Imunon, Inc.
Award(A)Direct1.3K shares at avg. $1.91$2K - Jun 25, 2026IMNN
Imunon, Inc.
Award(A)Direct21.9K shares at avg. $1.72$38K - Jan 2, 2026IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
12.7K shares- - Feb 18, 2025IMNN
Imunon, Inc.
Award(A)DirectStock Option (Right to Buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 23, 2026 | IMNN Imunon, Inc. | Award(A) | 1,092 | $1.24 | $1,349 | Direct |
| Oct 23, 2026 | IMNN Imunon, Inc. | Award(A) | 26,741 | $1.24 | $33,025 | Direct |
| Oct 9, 2026 | IMNN Imunon, Inc. | Award(A) | 1,249 | $1.08 | $1,349 | Direct |
| Sep 25, 2026 | IMNN Imunon, Inc. | Award(A) | 4,390 | $1.41 | $6,190 | Direct |
| Sep 11, 2026 | IMNN Imunon, Inc. | Award(A) | 4,211 | $1.47 | $6,190 | Direct |
| Aug 28, 2026 | IMNN Imunon, Inc. | Award(A) | 3,626 | $1.60 | $5,802 | Direct |
| Aug 14, 2026 | IMNN Imunon, Inc. | Award(A) | 3,516 | $1.65 | $5,801 | Direct |
| Jul 31, 2026 | IMNN Imunon, Inc. | Award(A) | 3,649 | $1.59 | $5,802 | Direct |
| Jul 17, 2026 | IMNN Imunon, Inc. | Award(A) | 3,082 | $1.83 | $5,640 | Direct |
| Jul 2, 2026 | IMNN Imunon, Inc. | Award(A) | 1,308 | $1.91 | $2,498 | Direct |
| Jun 25, 2026 | IMNN Imunon, Inc. | Award(A) | 21,896 | $1.72 | $37,661 | Direct |
| Jan 2, 2026 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 12,667 | - | - | Direct |
| Feb 18, 2025 | IMNN Imunon, Inc. | Award(A) Stock Option (Right to Buy) | 100,000 | - | - | Direct |
1-13 of 13 transactions
About Faller Douglas Vincent
Faller Douglas Vincent (SEC CIK 0002056033) files insider reports with the SEC as Chief Medical Officer of Imunon, Inc. (IMNN).
Signal8 holds 13 ownership filings by Faller Douglas Vincent (1 Form 3, 12 Form 4), filed between Feb 18, 2025 and Oct 27, 2026. Those filings report 13 transactions, from Feb 18, 2025 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Faller Douglas Vincent's filings is in LAWRENCEVILLE, NJ.
Recent filings by Faller Douglas Vincent
- Oct 23, 2026: Grants or awards of IMNN shares (2 lines, Form 4, code A).
- Oct 9, 2026: Grant or award of IMNN shares (Form 4, code A).
- Sep 25, 2026: Grant or award of IMNN shares (Form 4, code A).
- Sep 11, 2026: Grant or award of IMNN shares (Form 4, code A).
- Aug 28, 2026: Grant or award of IMNN shares (Form 4, code A).
Other insiders filing for Imunon, Inc. (IMNN)
- Tardugno Michael H, Executive Chairman of Board
- Lindborg Stacy, President and CEO
- Eylward Susan, General Counsel and Corp Sec
- Pellizzari Christine A, Director
- Dentzer James E, Director
- Fritz Frederick J., Director